Business
Tesla's First-ever Diner And Supercharger Opens In Los Angeles
Tesla electric vehicles charge outside the Tesla Diner and Drive-In restaurant, July 21, 2025 in Los Angeles, California (Photo by I RYU/VCG via Getty Images)
service charge

Tesla’s energy business has been juicing its top line for years — but now it’s starting to slow down too

Tesla’s services business is the new bright spot, as the EV maker’s energy division dropped 7% year on year.

Claire Yubin Oh

The last time we looked into Tesla’s energy business — and all the other parts of Tesla that aren’t selling cars — the world looked very different. The company’s CEO was growing increasingly close to presidential candidate Donald Trump, automotive sales were still growing (if only just), and the company’s robotaxi and AI efforts were future upside, rather than the core narrative of the stock today.

A lot has changed and there was no clearer signal of that than the latest earnings report on Wednesday, marking one of Tesla’s worst quarters in over a decade: revenue fell 12% year on year in Q2, including a 16% drop in automobile revenue.

With its traditional car-making business struggling with the rise of stronger rivals, deteriorating brand equity, and escalating tensions with President Trump, more investor focus is on the et cetera part of the company than ever before. But with just 10 to 20 robotaxis on the ground and AI-powered humanoid robots still a long way away, those are far from contributing commercially to the company’s bottom line.

Indeed, in the latest quarter, most Tesla divisions shrunk year on year, with revenue from regulatory credits — made from selling credits to legacy automakers that manufacture gas-burning cars to avoid fines — dropping 51% from the year before.

One bright spot was the the carmaker’s services and other business. That division includes used vehicle sales and maintenance services, but the main boost appears to be down to the continued growth of Tesla’s supercharger network, which has exploded ~7x in both the number of EV charging stations and connectors since 2018.

Tesla's superchargers are charging ahead
Sherwood News

As Tesla opened up the network to other brands, its been raking in more profits from non-Tesla drivers who use the superior charging facility at a cost, per a recent customer satisfaction survey of EV drivers.

That reversal of fortunes is particularly interesting, especially when looking at Tesla’s services division side-by-side with the energy business, which includes its solar energy generation and energy storage offerings. While its energy division is humming along, making a record $846 million gross profit this quarter, it’s no longer growing like wildfire as it was a year ago, back when it was the fastest-growing part of the company. It actually shrunk this quarter.

Tesla's energy business
Sherwood News

But hey, if the less sexy side hustles are working well, they might be worth doubling down on. Maybe in a few years time we’ll be writing about the billions that Tesla’s new diner division is raking in?

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Texas Governor Abbott And Google Make Economic Development Announcement In Midlothian

Alphabet could buy some pretty huge businesses with the amount of money it plans to spend this year

AI outlays have gone full nut-nut. Even Google, one of the most capital-efficient businesses of all time in its heyday, is spending like there’s no tomorrow.

Tom Jones2/6/26

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.